The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals
Open accessAbstract
Objective: Endoscopic ultrasonography (EUS) and MRI are promising tests to detect precursors and early-stage pancreatic ductal adenocarcinoma (PDAC) in high-risk individuals (HRIs). It is unclear which screening technique is to be preferred. We aimed to compare the efficacy of EUS and MRI in their ability to detect clinically relevant lesions in HRI. Design: Multicentre prospective study. The results of 139 asymptomatic HRI (>10-fold increased risk) undergoing first-time screening by EUS and MRI are described. Clinically relevant lesions were defined as solid lesions, main duct intraductal papillary mucinous neoplasms and cysts ≥10 mm. Results were compared in a blinded, independent fashion. Results: Two solid lesions (mean size 9 mm) and nine cysts ≥10 mm (mean size 17 mm) were detected in nine HRI (6%). Both solid lesions were detected by EUS only and proved to be a stage I PDAC and a multifocal pancreatic intraepithelial neoplasia 2. Of the nine cysts ≥10 mm, six were detected by both imaging techniques and three were detected by MRI only. The agreement between EUS and MRI for the detection of clinically relevant lesions was 55%. Of these clinically relevant lesions detected by both techniques, there was a good agreement for location and size. Conclusions: EUS and/or MRI detected clinically relevant pancreatic lesions in 6% of HRI. Both imaging techniques were complementary rather than interchangeable: contrary to EUS, MRI was found to be very sensitive for the detection of cystic lesions of any size; MRI, however, might have some important limitations with regard to the timely detection of solid lesions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas
Tanaka, M., Fernández-del Castillo, C., Adsay, V., Chari, S., Falconi, M., Jang, J.-Y., Kimura, W., Levy, P., Pitman, M. B., Schmidt, C. M., et al. (2012) · Pancreatology · doi:10.1016/j.pan.2012.04.004 · Cited by 2,354
Canto, M. I., Harinck, F., Hruban, R. H., Offerhaus, G. J., Poley, J.-W., Kamel, I., Nio, Y., Schulick, R. S., Bassi, C., Kluijt, I., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-303108 · Cited by 784
Self-citationFrequent detection of pancreatic lesions in asymptomatic high-risk individuals
Canto, M. I., Hruban, R. H., Fishman, E. K., Kamel, I. R., Schulick, R., Zhang, Z., Topazian, M., Takahashi, N., Fletcher, J., Petersen, G., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.01.005 · Cited by 648
The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
T. H. B. C. S. G., Iqbal, J., Ragone, A., Lubinski, J., Lynch, H. T., Moller, P., Ghadirian, P., Foulkes, W. D., Armel, S., Eisen, A., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.483 · Cited by 252
Vasen, H. F. A., Wasser, M., van Mil, A., Tollenaar, R. A., Konstantinovski, M., Gruis, N. A., Bergman, W., Hes, F. J., Hommes, D. W., Offerhaus, G. J. A., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.11.048 · Cited by 152
Research works printed but not linked: 21
- 10.3322/caac.20107 · DOI
- 10.1136/jmedgenet-2012-101277 · DOI
- Al-Sukhni W , Borgida A , Rothenmund H , et al . Screening for Pancreatic Cancer in a High-Risk Cohort: An Eight-Year Experience. J Gastrointest Surg 2011;16:771–83. doi:10.1007/s11605-011-1781-6 · DOI
- 10.7326/0003-4819-131-4-199908170-00003 · DOI · Paper page
- 10.1016/j.cgh.2006.02.005 · DOI · Paper page
- 10.1016/S1542-3565(04)00244-7 · DOI · Paper page
- 10.1136/gut.2008.171611 · DOI
- 10.1038/ajg.2011.65 · DOI
- 10.1038/ajg.2009.276 · DOI · Paper page
- 10.1158/1078-0432.CCR-09-3209 · DOI · Paper page
- 10.1158/1078-0432.CCR-08-0403 · DOI
- 10.1136/jmg.2004.028829 · DOI
- 10.1093/jnci/94.18.1358 · DOI
- 10.1136/jmg.2009.073429 · DOI
- 10.1136/gut.2006.108456 · DOI
- 10.2307/2529310 · DOI · Paper page
- 10.1016/S0016-5107(02)70092-8 · DOI
- 10.1007/s10689-010-9414-x · DOI · Paper page
- Shin, 2012, Radial versus linear and second look endoscopic ultrasound (EUS) improved detection of pancreatic lesions: a randomized tandem study, Gastrointest Endosc, 75, 131, 10.1016/j.gie.2012.04.037 · DOI
- 10.1016/j.bpg.2009.06.008 · DOI
- 10.1055/s-0033-1344956 · DOI
Cited by
Sorted by citations
Kleeff, J., Korc, M., Apte, M., La Vecchia, C., Johnson, C. D., Biankin, A. V., Neale, R. E., Tempero, M., Tuveson, D. A., Hruban, R. H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.22 · Cited by 1,982
Lin, J. S., Bowles, E. J. A., Williams, S. B., & Morrison, C. C. (2017) · JAMA · doi:10.1001/jama.2017.0562 · Cited by 1,082
Goggins, M., Overbeek, K. A., Brand, R., Syngal, S., Del Chiaro, M., Bartsch, D. K., Bassi, C., Carrato, A., Farrell, J., Fishman, E. K., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319352 · Cited by 659
Self-citationMultidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma
Grossberg, A. J., Chu, L. C. H., Deig, C. R., Fishman, E. K., Hwang, W. L., Maitra, A., Marks, D. L., Mehta, A., Nabavizadeh, N., Simeone, D. M., et al. (2020) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21626 · Cited by 500
US Preventive Services Task Force, Owens, D. K., Davidson, K. W., Krist, A. H., Barry, M. J., Cabana, M., Caughey, A. B., Curry, S. J., Doubeni, C. A., Epling, J. W., et al. (2019) · JAMA · doi:10.1001/jama.2019.10232 · Cited by 419
Canto, M. I., Almario, J. A., Schulick, R. D., Yeo, C. J., Klein, A., Blackford, A., Shin, E. J., Sanyal, A., Yenokyan, G., Lennon, A. M., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.05.035 · Cited by 414
Henderson, J. T., Webber, E. M., & Sawaya, G. F. (2018) · JAMA · doi:10.1001/jama.2017.21421 · Cited by 348
Vasen, H., Ibrahim, I., Ponce, C. G., Slater, E. P., Matthäi, E., Carrato, A., Earl, J., Robbers, K., van Mil, A. M., Potjer, T., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.0730 · Cited by 344
“Previous studies reported data on the yields of surveillance but did not address the benefit of programs in terms of survival.(10-14,16-21) In the current study, we evaluated the long-term outcome of prospective surveillance of a large series of CDKN2A/p16-Leiden mutation carriers, BRCA1/2 and PALB2 mutation carriers,…”
BackgroundAGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review
Aslanian, H. R., Lee, J. H., & Canto, M. I. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.03.088 · Cited by 317
Multicenter study of early pancreatic cancer in Japan
Kanno, A., Masamune, A., Hanada, K., Maguchi, H., Shimizu, Y., Ueki, T., Hasebe, O., Ohtsuka, T., Nakamura, M., Takenaka, M., et al. (2018) · Pancreatology · doi:10.1016/j.pan.2017.11.007 · Cited by 291
“[18] reported the complementary roles of EUS and MRI in detecting pancreatic lesions in”
BackgroundDiagnosis and Detection of Pancreatic Cancer
Chu, L. C. H., Goggins, M., & Fishman, E. K. (2017) · The Cancer Journal · doi:10.1097/ppo.0000000000000290 · Cited by 304
“A meta-analysis that evaluated 4 studies comparing EUS in the setting of a negative or inconclusive CT found EUS to have superior accuracy for detecting pancreatic cancer masses, but 3 of the 4 studies were undertakenmore than a decade ago.68 A recent study comparing EUS toMRI/MRCP found EUS examination detected a sma…”
ResultBoursi, B., Finkelman, B., Giantonio, B. J., Haynes, K., Rustgi, A. K., Rhim, A. D., Mamtani, R., & Yang, Y.-X. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.11.046 · Cited by 202
Săftoiu, A., Hassan, C., Areia, M., Bhutani, M., Bisschops, R., Bories, E., Cazacu, I., Dekker, E., Deprez, P., Pereira, S., et al. (2020) · Endoscopy · doi:10.1055/a-1104-5245 · Cited by 187
“However, it has been shown that EUS was particularly sensitive for the early detection of small solid lesions, while MRI was very sensitive for the detection of (small) cystic lesions [107].”
BackgroundLong-term yield of pancreatic cancer surveillance in high-risk individuals
Overbeek, K. A., Levink, I. J. M., Koopmann, B. D. M., Harinck, F., Konings, I. C. A. W., Ausems, M. G. E. M., Wagner, A., Fockens, P., van Eijck, C. H., Groot Koerkamp, B., et al. (2022) · Gut · doi:10.1136/gutjnl-2020-323611 · Cited by 164
Self-citationPancreatic Cancer Surveillance and Survival of High-Risk Individuals
Blackford, A. L., Canto, M. I., Dbouk, M. H., Hruban, R. H., Katona, B. W., Chak, A., Brand, R. E., Syngal, S., Farrell, J. J., Kastrinos, F., et al. (2024) · JAMA Oncology · doi:10.1001/jamaoncol.2024.1930 · Cited by 178
Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review
Kenner, B., Chari, S. T., Kelsen, D., Klimstra, D. S., Pandol, S. J., Rosenthal, M., Rustgi, A. K., Taylor, J. A., Yala, A., Abul-Husn, N., et al. (2021) · Pancreas · doi:10.1097/mpa.0000000000001762 · Cited by 158
The role of endoscopy in the evaluation and management of patients with solid pancreatic neoplasia
Eloubeidi, M. A., Decker, G. A., Chandrasekhara, V., Chathadi, K. V., Early, D. S., Evans, J. A., Fanelli, R. D., Fisher, D. A., Foley, K., Hwang, J. H., et al. (2016) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2015.09.009 · Cited by 146
“MRI, however, might have some important limitations with regard to the timely detection of solid lesions.(138) Screening is best performed within research protocols or registries involving multidisciplinary teams with expertise in genetics, gastroenterology, radiology, surgery, and pathology.”
BackgroundHenrikson, N. B., Aiello Bowles, E. J., Blasi, P. R., Morrison, C. C., Nguyen, M., Pillarisetty, V. G., & Lin, J. S. (2019) · JAMA · doi:10.1001/jama.2019.6190 · Cited by 140
The Management of Peutz–Jeghers Syndrome: European Hereditary Tumour Group (EHTG) Guideline
Wagner, A., Aretz, S., Auranen, A., Bruno, M. J., Cavestro, G. M., Crosbie, E. J., Goverde, A., Jelsig, A. M., Latchford, A. R., van Leerdam, M. E., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030473 · Cited by 151
“demonstrated that, contrary to EUS, MRI was more sensitive for cystic lesions detection, with important limitations in solid lesions detection [60].”
ResultSelf-citationSawhney, M., Calderwood, A. H., Thosani, N. C., Rebbeck, T. R., Wani, S. B., Canto, M. I., Fishman, D. S., Golan, T., Hidalgo, M. M., Kwon, R. S., et al. (2022) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2021.12.001 · Cited by 158
Familial pancreatic cancer: Concept, management and issues
Matsubayashi, H., Takaori, K., Morizane, C., Maguchi, H., Mizuma, M., Takahashi, H., Wada, K., Hosoi, H., Yachida, S., Suzuki, M., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i6.935 · Cited by 109
Zhang, J., Zhu, L., Yao, L., Ding, X., Chen, D., Wu, H., Lu, Z., Zhou, W., Zhang, L., An, P., et al. (2020) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2020.04.071 · Cited by 110
Nakahodo, J., Kikuyama, M., Nojiri, S., Chiba, K., Yoshimoto, K., Kamisawa, T., Horiguchi, S.-I., & Honda, G. (2020) · Pancreatology · doi:10.1016/j.pan.2020.09.020 · Cited by 87
Early Diagnosis to Improve the Poor Prognosis of Pancreatic Cancer
Kikuyama, M., Kamisawa, T., Kuruma, S., Chiba, K., Kawaguchi, S., Terada, S., & Satoh, T. (2018) · Cancers · doi:10.3390/cancers10020048 · Cited by 79
Canto, M. I., Kerdsirichairat, T., Yeo, C. J., Hruban, R. H., Shin, E. J., Almario, J. A., Blackford, A. L., Ford, M., Klein, A. P., Javed, A. A., et al. (2019) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-019-04230-z · Cited by 82
Krishna, S., Rao, B., Ugbarugba, E. E., Shah, Z., Blaszczak, A. M., Hinton, A., Conwell, D., & Hart, P. (2017) · Surgical Endoscopy · doi:10.1007/s00464-017-5516-y · Cited by 69
“Considering prospective PDAC screening studies that have demonstrated that EUS is more sensitive for early diagnosis of a solid pancreatic neoplasm compared to MDCT or MRI/MRCP, we favor repeating an EUS in 2–3 months; however, this approach requires further study [27].”
BackgroundDas, K. K., & Early, D. S. (2017) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-017-0149-8 · Cited by 19
Beyer, G., Hoffmeister, A., Michl, P., Gress, T. M., Huber, W., Algül, H., Neeße, A., Meining, A. G., Seufferlein, T. T. W., Rosendahl, J., et al. (2022) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1735-3864 · Cited by 108
The Role of Imaging in Current Treatment Strategies for Pancreatic Adenocarcinoma
Rhee, H., & Park, M. (2020) · Korean Journal of Radiology · doi:10.3348/kjr.2019.0862 · Cited by 77
“However, MRI is more sensitive in the detection of cystic lesions and main pancreatic duct communication, allowing the diagnosis of intraductal papillary mucinous neoplasm, which is considered to be a precancerous lesion (24, 26).”
BackgroundPaiella, S., Salvia, R., Pastena, M. D., Pollini, T., Casetti, L., Landoni, L., Esposito, A., Marchegiani, G., Malleo, G., Marchi, G. D., et al. (2018) · Pancreatology · doi:10.1016/j.pan.2018.04.002 · Cited by 71
Signoretti, M., Bruno, M. J., Zerboni, G., Poley, J., Fave, G. D., & Capurso, G. (2018) · United European Gastroenterology Journal · doi:10.1177/2050640617752182 · Cited by 62
Self-citationCurrent Approaches to Pancreatic Cancer Screening
Chhoda, A., Lu, L., Clerkin, B. M., Risch, H. A., & Farrell, J. J. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.09.013 · Cited by 64
Pancreatic cancer screening in high-risk individuals with germline genetic mutations
Davee, T. R., Coronel, E. S., Papafragkakis, C., Thaiudom, S., Lanke, G., Chakinala, R. C., Nogueras‐González, G. M., Bhutani, M. S., Ross, W. A., Weston, B. R., et al. (2018) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2017.12.019 · Cited by 56
Non-coding RNA biomarkers in pancreatic ductal adenocarcinoma
Sharma, G. G., Okada, Y., Hoff, D. D. V., & Goel, A. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.10.001 · Cited by 54
Paiella, S., Capurso, G., Cavestro, G. M., Butturini, G., Pezzilli, R., Salvia, R., Signoretti, M., Crippa, S., Carrara, S., Frigerio, I. M., et al. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0414-z · Cited by 51
Advances in Early Detection of Pancreatic Cancer
Kanno, A., Masamune, A., Hanada, K., Kikuyama, M., & Kitano, M. (2019) · Diagnostics · doi:10.3390/diagnostics9010018 · Cited by 56
“hereditary pancreatic carcinoma syndrome [14].”
Lutz, M. P., Zalcberg, J. R., Ducreux, M. P., Aust, D. E., Bruno, M. J., Büchler, M. W., Delpéro, J., Gloor, B., Glynne‐Jones, R., Hartwig, W., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.03.022 · Cited by 45
Self-citationCurrent epidemiology of pancreatic cancer: Challenges and opportunities
Luo, W.-H., Tao, J.-X., Zheng, L.-F., & Zhang, T.-P. (2020) · Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · doi:10.21147/j.issn.1000-9604.2020.06.04 · Cited by 47
“years) in the four individuals who did not undergo recommended surveillance (97).”
BackgroundGonoi, W., Hayashi, T. Y., Okuma, H., Akahane, M., Nakai, Y., Mizuno, S., Tateishi, R., Isayama, H., Koike, K., & Ohtomo, K. (2017) · European Radiology · doi:10.1007/s00330-017-4895-8 · Cited by 55
Klatte, D. C. F., Wallace, M. B., Löhr, M. J., Bruno, M. J., & van Leerdam, M. E. (2022) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2021.101783 · Cited by 68
Self-citationFamilial Pancreatic Cancer: Current Perspectives
Llach, J., Carballal, S., & Moreira, L. (2020) · Cancer Management and Research · doi:10.2147/cmar.s172421 · Cited by 51
“Harinck et al observed that MRI and EUS results are complementary since MRI seems to show a greater sensitivity in the identification of cystic lesions and EUS in the detection of solid lesions.(66) However, given its ability to take ultrasound-guided fine needle aspiration and to detect lesions measuring less than 10…”
BackgroundKonings, I. C. A. W., Harinck, F., Poley, J.-W., Aalfs, C. M., van Rens, A., Krak, N. C., Wagner, A., Nio, C. Y., Sijmons, R. H., van Dullemen, H. M., et al. (2017) · Pancreas · doi:10.1097/mpa.0000000000000725 · Cited by 41
Self-citationKumar, A. A., Buckley, B. J., & Ranson, M. (2022) · Biomolecules · doi:10.3390/biom12020152 · Cited by 47
Diagnostic Endoscopic Ultrasound: Technique, Current Status and Future Directions
Ang, T., Kwek, A., & Wang, L.-M. (2018) · Gut and Liver · doi:10.5009/gnl17348 · Cited by 39
Pancreatic Cysts and Guidelines
Farrell, J. J. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4571-5 · Cited by 49
de Moura, D. T. H., Ryou, M. K., de Moura, E. G. H., Ribeiro, I. B., Bernardo, W. M., & Thompson, C. C. (2019) · Clinical Endoscopy · doi:10.5946/ce.2019.053 · Cited by 46
Huang, C., Simeone, D. M., Luk, L., Hecht, E. M., Khatri, G., Kambadakone, A. R., Chandarana, H., Ream, J., Everett, J. N., Guimarães, A. R., et al. (2022) · American Journal of Roentgenology · doi:10.2214/ajr.22.27859 · Cited by 40
Endoscopic ultrasound findings and pathological features of pancreatic carcinoma in situ
Izumi, Y., Hanada, K., Okazaki, A., Minami, T., Hirano, N., Ikemoto, J., Kanemitsu, K., Nakadoi, K., Shishido, T., Katamura, Y., et al. (2019) · Endoscopy International Open · doi:10.1055/a-0839-4312 · Cited by 37
“[16] reported that EUS and/or MRI detected clinically relevant pancreatic lesions in 6% of high-risk individuals, and both imaging techniques were complementary rather than interchangeable.”
BackgroundSheel, A. R. G., Harrison, S., Sarantitis, I., Nicholson, J. A., Hanna, T., Grocock, C., Raraty, M., Ramesh, J., Farooq, A., Costello, E., et al. (2019) · American Journal of Gastroenterology · doi:10.1038/s41395-018-0395-y · Cited by 36
Bian, J., Xu, Y., Sun, M., Ma, Z., Li, H., Sun, C., Xiong, F., Zhao, X., Yao, W., Chen, Y., et al. (2024) · ACS Nano · doi:10.1021/acsnano.4c07403 · Cited by 37
Bekkali, N. L. H., & Oppong, K. (2017) · Endoscopic Ultrasound · doi:10.4103/eus.eus_60_17 · Cited by 35
“As EUS and MRI are complementary, many units alternate screening/investigations using EUS and MRI.[17] In addition, EUS enables biopsy acquisition (fine needle aspiration/biopsy) in cases where lesions are found.”
BackgroundKonings, I. C. A. W., Harinck, F., Kuenen, M. A., Sidharta, G. N., Kieffer, J. M., Aalfs, C. M., Poley, J., Smets, E. M. A., Wagner, A., van Rens, A., et al. (2016) · Familial Cancer · doi:10.1007/s10689-016-9930-4 · Cited by 39
“The clinical study procedures were previously extensively described [25].”
Self-citationSagami, R., Yamao, K., Nakahodo, J., Minami, R., Tsurusaki, M., Murakami, K., & Amano, Y. (2021) · Cancers · doi:10.3390/cancers13050945 · Cited by 45
Yang, S., Kuo, T., Wu, H., Guo, J., Hsu, C., Hsu, C., Tien, Y., Yeh, K., Cheng, A., & Kuo, S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i32.7275 · Cited by 33
The Role of Endoscopic Ultrasonography in the Diagnosis and Staging of Pancreatic Cancer
Zakaria, A., Al-Share, B. A., Klapman, J. B., & Dam, A. N. (2022) · Cancers · doi:10.3390/cancers14061373 · Cited by 34
“EUS detected more solid lesions than MRI/MRCP, while MRI/MRCP was more sensitive to cystic lesions of any size [77,78].”
BackgroundSurveillance for pancreatic cancer in high‐risk individuals
Konings, I. C. A. W., Canto, M. I., Almario, J. A., Harinck, F., Saxena, P., Lucas, A. L., Kastrinos, F., Whitcomb, D. C., Brand, R. E., Lachter, J., et al. (2019) · BJS Open · doi:10.1002/bjs5.50180 · Cited by 36
Self-citationSurveillance for neoplasia in the pancreas
Overbeek, K. A., Cahen, D. L., Canto, M. I., & Bruno, M. J. (2016) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.10.013 · Cited by 28
Self-citationSurveillance of high-risk individuals for pancreatic cancer with EUS and MRI: A meta-analysis.
Kogekar, N., Diaz, K., Weinberg, A., & Lucas, A. (2020) · Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] · doi:10.26226/morressier.5ebc4ac6ffea6f735881a3f6 · Cited by 28
Familial Pancreatic Cancer and the Future of Directed Screening
Welinsky, S., & Lucas, A. L. (2017) · Gut and Liver · doi:10.5009/gnl16414 · Cited by 33
Lu, Y., Chen, L., Li, C.-J., Chen, H.-L., & Chen, J. (2017) · Medical ultrasonography · doi:10.11152/mu-987 · Cited by 28
“A previous study has shown that, magnetic resonance imaging (MRI) was very sensitive to detect pancreatic cystic lesions, while endoscopic ultrasonography (EUS) showed its superiority in solid lesions [3].”
BackgroundXue, S., Gafita, A., Zhao, Y. S., Mercolli, L., Cheng, F., Rauscher, I., D’Alessandria, C., Seifert, R., Afshar‐Oromieh, A., Rominger, A., et al. (2024) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-024-06737-3 · Cited by 31
Saba, H., & Goggins, M. (2022) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2022.06.006 · Cited by 20
Calderwood, A. H., Sawhney, M., Thosani, N. C., Rebbeck, T. R., Wani, S. B., Canto, M. I., Fishman, D. S., Golan, T., Hidalgo, M. M., Kwon, R. S., et al. (2022) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2021.12.002 · Cited by 30
Vullierme, M., Menassa, L., Couvelard, A., Rebours, V., Maire, F., Ibrahim, T., Cros, J. F., Ruszniewski, P. B., Sauvanet, A., Lévy, P., et al. (2019) · European Radiology · doi:10.1007/s00330-019-06154-3 · Cited by 23
Chronic pancreatitis changes in high-risk individuals for pancreatic ductal adenocarcinoma
Thiruvengadam, S. S., Chuang, J., Huang, R. J., Girotra, M., & Park, W. G. (2018) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2018.08.029 · Cited by 26
Ishida, J., Toyama, H., Matsumoto, I., Asari, S., Goto, T., Terai, S., Nanno, Y., Yamashita, A., Mizumoto, T., Ueda, Y., et al. (2016) · Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] · doi:10.1016/j.pan.2016.05.003 · Cited by 23
Boekestijn, B., Feshtali, S., Vasen, H. F. A., van Leerdam, M. E., Bonsing, B. A., Mieog, J. S. D., & Wasser, M. N. J. M. (2024) · Familial Cancer · doi:10.1007/s10689-024-00394-z · Cited by 20
Association of Glycated Hemoglobin Levels With Risk of Pancreatic Cancer
Wu, B. U., Butler, R. K., Lustigova, E., Lawrence, J. M., & Chen, W. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.4945 · Cited by 26
Lee, L. S., Andersen, D., Ashida, R., Brugge, W., Canto, M., Chang, K., Chari, S., DeWitt, J., Hwang, J., Khashab, M., et al. (2017) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2017.08.006 · Cited by 22
Lorenzo, D., Rebours, V., Maire, F., Palazzo, M., Gonzalez, J., Vullierme, M., Aubert, A., Hammel, P. R., Lévy, P., & de Mestier, L. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i34.5082 · Cited by 25
Proposal for Endoscopic Ultrasonography Classification for Small Pancreatic Cancer
Terada, S., Kikuyama, M., Kawaguchi, S., Kanemoto, H., Yokoi, Y., Kamisawa, T., Kuruma, S., Chiba, K., Honda, G., Horiguchi, S., et al. (2019) · Diagnostics · doi:10.3390/diagnostics9010015 · Cited by 21
Lee, L. S., Andersen, D., Ashida, R., Brugge, W., Canto, M., Chang, K., Chari, S., DeWitt, J., Hwang, J., Khashab, M., et al. (2017) · Pancreas · doi:10.1097/mpa.0000000000000936 · Cited by 21
What should be known prior to performing EUS?
Dietrich, C., Arcidiacono, P., Braden, B., Burmeister, S., Carrara, S., Cui, X.-W., Leo, M. D., Dong, Y., Fusaroli, P., Gilja, O., et al. (2019) · Endoscopic Ultrasound · doi:10.4103/eus.eus_54_18 · Cited by 19
“Introduction Combining TUS or other cross-sectional imaging with EUS may provide complementary information, for example, in oncological staging, but also in gastric, biliary and endocrine diseases, cystic and solid pancreatic lesions, or idiopathic acute and chronic pancreatitis.[28-34] The topic was controversially d…”
BackgroundScreening for pancreatic cancer has the potential to save lives, but is it practical?
Mazer, B. L., Lee, J. W., Roberts, N. J., Chu, L. C. H., Lennon, A. M., Klein, A. P., Eshleman, J. R., Fishman, E. K., Canto, M. I., Goggins, M., et al. (2023) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2023.2217354 · Cited by 24
“Harinck and colleagues compared endoscopic ultrasound to magnetic resonance imaging in a screening study of 139 asymptomatic high-risk individuals [131].”
ResultCurrent Screening Strategies for Pancreatic Cancer
Vaněk, P., Urban, O., Zoundjiekpon, V., & Falt, P. (2022) · Biomedicines · doi:10.3390/biomedicines10092056 · Cited by 21
The Role of MR Imaging in Pancreatic Cancer.
Jha, P., Yeh, B. M., Zagoria, R., Collisson, E., & Wang, Z. (2018) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2018.03.004 · Cited by 18
Kumar, S., Saumoy, M., Oh, A., Schneider, Y., Brand, R. E., Chak, A., Ginsberg, G. G., Kochman, M. L., Canto, M. I., Goggins, M., et al. (2021) · Pancreas · doi:10.1097/mpa.0000000000001835 · Cited by 24
the Dutch Familial Pancreatic Cancer Surveillance Study Group, Overbeek, K. A., Cahen, D. L., Kamps, A., Konings, I. C. A. W., Harinck, F., Kuenen, M. A., Koerkamp, B. G., Besselink, M. G., van Eijck, C. H. J., et al. (2020) · Familial Cancer · doi:10.1007/s10689-020-00171-8 · Cited by 19
Self-citationShah, I., Silva-Santisteban, A., Germansky, K. A., Trindade, A., Raphael, K. L., Kushnir, V., Pawa, R., Mishra, G., Anastasiou, J., Inamdar, S., et al. (2023) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002314 · Cited by 15
“In a multicenter study of 139 high-risk individuals undergoing screening, 2 solid lesions (mean size 9 mm) were detected by EUS alone (23).”
Scholten, L., Latenstein, A. E. J., Aalfs, C. M., Bruno, M. J., Busch, O. R., Bonsing, B. A., Koerkamp, B. G., Molenaar, I. Q., Ubbink, D. T., van Hooft, J. E., et al. (2020) · United European Gastroenterology Journal · doi:10.1177/2050640620945534 · Cited by 15
“In some countries, individuals with a high risk of developing PDAC may enter a dedicated screening programme in a research setting.(9,10) Such a programme has also been introduced in The Netherlands.”
BackgroundSelf-citationInherited predisposition to pancreatic cancer
Hilfrank, K. J., Rustgi, S. D., & Kastrinos, F. (2021) · Seminars in Oncology · doi:10.1053/j.seminoncol.2021.02.006 · Cited by 3
Ishii, Y., Serikawa, M., Tsuboi, T., Kawamura, R., Tsushima, K., Nakamura, S., Hirano, T., Fukiage, A., Mori, T., Ikemoto, J., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11020238 · Cited by 17
“[51] also reported that 11 mm and 7 mm solid lesions and nine cysts of 10 mm and above were found in nine patients (6%) in a comparative prospective trial of EUS and MRI detection rates for clinically relevant lesions at the first screening for 139 asymptomatic HRIs.”
BackgroundKurita, A., Mori, Y., Someya, Y., Kubo, S., Azuma, S., Iwano, K., Ikeda, S., Okumura, R., & Yazumi, S. (2021) · Abdominal Radiology · doi:10.1007/s00261-021-03199-1 · Cited by 13
Early detection of pancreatic cancer in the era of precision medicine
Ahmed, T. M., Kawamoto, S., Lopez-Ramirez, F., Yasrab, M., Hruban, R. H., Fishman, E. K., & Chu, L. C. H. (2024) · Abdominal Radiology · doi:10.1007/s00261-024-04358-w · Cited by 12
“MRI and EUS have been demonstrated to be particularly effective in tandem, with MRI being especially sensitive for cystic lesion and EUS for solid lesions [23].”
The role of endoscopic ultrasound in the detection of pancreatic lesions in high-risk individuals
Overbeek, K. A., Cahen, D. L., & Bruno, M. J. (2024) · Familial Cancer · doi:10.1007/s10689-024-00380-5 · Cited by 11
“The sensitivity of EUS to detect cystic lesions in high-risk individuals has been compared in a blinded fashion in one study by Harinck et al. They compared baseline EUS to baseline MRI/MRCP in 139 high-risk individuals, and found a sensitivity for cystic lesions of 39% for EUS and 90% for MRI [87].”
Self-citationAspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer
Bogdanski, A. M., van Hooft, J. E., Boekestijn, B., Bonsing, B. A., Wasser, M. N. J. M., Klatte, D. C. F., & van Leerdam, M. E. (2024) · Familial Cancer · doi:10.1007/s10689-024-00368-1 · Cited by 12
Kikuyama, M., Nakahodo, J., Honda, G., Suzuki, M., Horiguchi, S., Chiba, K., Tabata, H., Ome, Y., Uemura, S., Kawamoto, Y., et al. (2023) · Pancreatology · doi:10.1016/j.pan.2023.03.002 · Cited by 10
COVID-19 related pancreatic cancer surveillance disruptions amongst high-risk individuals
Katona, B. W., Mahmud, N., Dbouk, M. H., Ahmad, N. A., Chhoda, A., Dudley, B., Hayat, U., Kwon, R. S., Lee, L., Rustgi, A. K., et al. (2021) · Pancreatology · doi:10.1016/j.pan.2021.04.005 · Cited by 12
de Mestier, L., Müller, M., Cros, J. F., Vullierme, M., Vernerey, D., Maire, F., Dokmak, S., Rebours, V., Sauvanet, A., Lévy, P., et al. (2019) · United European Gastroenterology Journal · doi:10.1177/2050640618824910 · Cited by 14
Challenges of early detection of pancreatic cancer
Shen, M. J., Jamali, A., & Katona, B. W. (2025) · Journal of Clinical Investigation · doi:10.1172/jci191942 · Cited by 24
“This was supported by a 2022 study from the Netherlands, where EUS was superior to MRI/MRCP for the detection of solid lesions, whereas MRI/MRCP outperformed EUS in detecting cystic lesions, primarily driven by increased detection of sub-centimeter-sized cysts (15).”
Bang, J. Y., Săftoiu, A., Udriștoiu, Ș., Gruionu, L. G., Gheorghe, E. C., Gruionu, G., Ramesh, J., Wilcox, C. M., & Varadarajulu, S. (2025) · Endoscopy · doi:10.1055/a-2701-6530 · Cited by 10
Huang, C., Hecht, E. M., Soloff, E. V., Tiwari, H. A., Bhosale, P., Dasayam, A., Galgano, S. J., Kambadakone, A., Kulkarni, N. M., Le, O., et al. (2024) · American Journal of Roentgenology · doi:10.2214/ajr.24.31151 · Cited by 13
Kuruma, S., Kikuyama, M., Chiba, K., Yoshimoto, K., Kamisawa, T., Honda, G., Horiguchi, S., & Nakahodo, J. (2019) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-019-01065-8 · Cited by 10
Current Status of Endoscopic Ultrasound Techniques for Pancreatic Neoplasms
Nakai, Y., Takahara, N., Mizuno, S., Kogure, H., & Koike, K. (2019) · Clinical Endoscopy · doi:10.5946/ce.2019.025 · Cited by 10
“Both EUS and MRI had a role in the screening program for high-risk individuals (Table 1).(39) While MRI can detect small pancreatic cysts, EUS is sensitive for the detection of small solid lesions.”
BackgroundFarrell, J. (2018) · Endoscopic Ultrasound · doi:10.4103/eus.eus_49_18 · Cited by 12
“317 ENDOSCOPIC ULTRASOUND / VOLUME 7 | ISSUE 5 / SEPTEMBER-OCTOBER 2018 PanIN lesions.[22,23] There are no specific fluid-based or imaging (e.”
BackgroundCost-Effectiveness Analysis of Screening for Pancreatic Cancer Among High-Risk Populations
Peters, M. L. B., Eckel, A. L., Seguin, C. L., Davidi, B., Howard, D. H., Knudsen, A. B., & Pandharipande, P. V. (2023) · JCO Oncology Practice · doi:10.1200/op.23.00495 · Cited by 22
Pancreatic Cancer Surveillance: Who, When, and How
Dudley, B., & Brand, R. E. (2019) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-019-00247-0 · Cited by 12
Vasen, H. F. A. (2017) · Familial Cancer · doi:10.1007/s10689-017-0066-y · Cited by 10
Pancreatic Cancer Surveillance and Novel Strategies for Screening
Dudley, B., & Brand, R. E. (2021) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2021.08.008 · Cited by 10
Lee, J. H., Min, J., Kim, Y. K., Cha, D., Lee, J.-S., Park, H., & Ahn, S. (2019) · Clinical imaging · doi:10.1016/j.clinimag.2019.02.013 · Cited by 8
Metadata
- Authors
- Harinck, F., Konings, I. C. A. W., Kluijt, I., Poley, J. W., van Hooft, J. E., van Dullemen, H. M., Nio, C. Y., Krak, N. C., Hermans, J. J., Aalfs, C. M., Wagner, A., Sijmons, R. H., Biermann, K., van Eijck, C. H., Gouma, D. J., Dijkgraaf, M. G. W., Fockens, P., & Bruno, M. J.
- Affiliations
- Erasmus MC (NL)
- The Netherlands Cancer Institute (NL)
- Amsterdam University Medical Centers (NL)
- University Medical Center Groningen (NL)
- Radboud University Medical Center (NL)
- Corresponding author
- Harinck, F
- ORCID
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2015-05-18
- Volume
- 65
- Issue
- 9
- Pages
- 1505-1513
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W1907808487
- Cited by
- 185
- References
- 0
- Citations by year
- 2026: 13 · 2025: 6 · 2024: 16 · 2023: 16 · 2022: 21 · 2021: 19 · 2020: 16 · 2019: 23 · 2018: 18 · 2017: 19 · 2016: 15 · 2015: 3
- FWCI
- 7.97
- Type
- journal article
- Language
- en
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- other-oa
- Locations
- Gut (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- ZonMw (120520016)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Keywords
- pancreatic cancer screening, endoscopic ultrasound, magnetic resonance imaging, pancreatic ductal adenocarcinoma, high-risk individuals, intraductal papillary mucinous neoplasm, pancreatic cysts, pancreatic intraepithelial neoplasia, solid pancreatic lesions, diagnostic agreement, early cancer detection
- MeSH terms
- Adult, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Netherlands, Pancreas, Pancreatic Cyst, Pancreatic Neoplasms, Prospective Studies, Cohort Studies, Endosonography, Carcinoma, Pancreatic Ductal, Early Detection of Cancer, Comparative Effectiveness Research, Asymptomatic Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review